Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Neurocysticercosis-Associated Meningitis: A Systematic Review
Ravindra Kumar Garg1, Neeraj Kumar2, Vinay Suresh3
1Department of Neurology, Era's Lucknow Medical College and Hospital, Era University, Lucknow, Uttar Pradesh, India.
Abstract:
Neurocysticercosis is a frequent parasitic infection of the central nervous system. While parenchymal forms are well recognized, meningitis due to cysticercus remains underdiagnosed. This systematic review assessed clinical features, diagnostics, treatment, and outcomes of neurocysticercosis-associated meningitis. Following PRISMA guidelines and PROSPERO registration, case reports, series, and cohorts describing meningitis attributed to neurocysticercosis were analyzed. Extracted data included demographics, presentation, imaging, cerebrospinal fluid (CSF) findings, diagnostics, therapy, and outcomes. A total of 48 published cases of neurocysticercosis-associated meningitis were analyzed. Headache was the most common presenting symptom (45 cases, 94%), followed by fever and vomiting (20 cases each, 42%), visual impairment or gait disturbance (16 cases, 33%), altered sensorium (15 cases, 31%), and seizures (13 cases, 27%). Chronic meningitis (13 cases, 27%) and meningoencephalitis (10 cases, 21%) were the most frequent subtypes. Neuroimaging most often showed subarachnoid or racemose cysts (14 cases, 29%) and hydrocephalus (13 cases, 27%). Cerebrospinal fluid analysis revealed elevated opening pressure (27 cases, 56%), lymphocytic pleocytosis (25 cases, 52%), eosinophilic pleocytosis (12 cases, 25%), elevated protein (42 cases, 88%), and low glucose (35 cases, 73%). Surgical intervention was required in 26 cases (54%). Albendazole, corticosteroids, and praziquantel were used in 42 (88%), 21 (44%), and 18 (38%) cases, respectively. Complete recovery occurred in 17 cases (35%), and mortality in 3 cases (6%). Neurocysticercosis-associated meningitis is a severe, often subarachnoid disease marked by diagnostic delay and frequent surgical need, but outcomes are favorable when timely, individualized medical/ surgical management is instituted.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction

